Valuation (14%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -9.45 | N/A |
PEG Ratio (TTM) | 0.45 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | -17.18 | N/A |
P/FCF Ratio (TTM) | -110.80 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -194.17% | N/A |
ROE (TTM) | -3,433.55% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 45,030,275.65% | N/A | N/A |
Revenue | -25.00% | N/A | N/A |
Net Income | 44,801.84% | N/A | N/A |
Cash Flow | -1,635.35% | N/A | N/A |
Health (25%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.17 | N/A |
Quick Ratio (TTM) | 0.17 | N/A |
D/E Ratio (TTM) | -0.52 | N/A |
Interest Coverage (TTM) | -1,197.27 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 5.56 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |